Cell cycle-dependent regulation of the Skp2 promoter by GA-binding protein

Cancer Research

Volumn 63, Issue 15, 2003, Pages 4607-4613

  Imaki, Hiroyuki ^a,b   Nakayama, Keiko ^a,b   Delehouzee, Sophie ^c   Handa, Hiroshi ^c   Kitagawa, Masatoshi ^a,b,d   Kamura, Takumi ^a,b   Nakayama, Keiichi I ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^d HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CELL PROTEIN; GA BINDING PROTEIN; GA BINDING PROTEIN BETA; LIGASE; LUCIFERASE; MESSENGER RNA; PROTEIN P27; S PHASE KINASE ASSOCIATED PROTEIN 2; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; SITE DIRECTED MUTAGENESIS;

3T3 CELLS; ANIMALS; BASE SEQUENCE; CELL CYCLE; CELL CYCLE PROTEINS; DNA; DNA-BINDING PROTEINS; GA-BINDING PROTEIN TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GENES, REGULATOR; HELA CELLS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; RNA, SMALL INTERFERING; S-PHASE KINASE-ASSOCIATED PROTEINS; TRANSCRIPTION FACTORS;

EID: 0041633899     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Weissman, A. M. Regulating protein degradation by ubiquitination. Immunol. Today, 18: 189-198, 1997.
2. Hershko, A., and Ciechanover, A. The ubiquitin system. Annu. Rev. Biochem., 67: 425-479, 1998.
3. Hershko, A., Heller, H., Elias, S., and Ciechanover, A. Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown. J. Biol. Chem., 258: 8206-8214, 1983.
4. Scheffner, M., Nuber, U., and Huibregtse, J. M. Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature (Lond.), 373: 81-83, 1995.
5. Bai, C., Sen, P., Hofmann, K., Ma, L., Goebl, M., Harper, J. W., and Elledge, S. J. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell, 86: 263-274, 1996.
6. Feldman, R. M., Correll, C. C., Kaplan, K. B., and Deshaies, R. J. A complex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p. Cell, 91: 221-230, 1997.
7. Skowyra, D., Craig, K. L., Tyers, M., Elledge, S. J., and Harper, J. W. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell, 91: 209-219, 1997.
8. Zhang, H., Kobayashi, R., Galaktionov, K., and Beach, D. p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell, 82: 915-925, 1995.
9. Carrano, A. C., Eytan, E., Hershko, A., and Pagano, M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol., 1: 193-199, 1999.
10. Tsvetkov, L. M., Yeh, K. H., Lee, S. J., Sun, H., and Zhang, H. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr. Biol., 9: 661-664, 1999.
11. Nakayama, K., Nagahama, H., Minamishima, Y. A., Matsumoto, M., Nakamichi, I., Kitagawa, K., Shirane, M., Tsunematsu, R., Tsukiyama, T., Ishida, N., Kitagawa, M., Nakayama, K. I., and Hatakeyama, S. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J., 19: 2069-2081, 2000.
12. Gstaiger, M., Jordan, R., Lim, M., Catzavelos, C., Mestan, J., Slingerland, J., and Krek, W. Skp2 is oncogenic and overexpressed in human cancers. Proc. Natl. Acad. Sci. USA, 98: 5043-5048, 2001.
13. Hershko, D., Bornstein, G., Ben-Izhak, O., Carrano, A., Pagano, M., Krausz, M. M., and Hershko, A. Inverse relation between levels of p27(Kip1) and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas. Cancer (Phila.), 91: 1745-1751, 2001.
14. Latres, E., Chiarle, R., Schulman, B. A., Pavletich, N. P., Pellicer, A., Inghirami, G., and Pagano, M. Role of the F-box protein Skp2 in lymphomagenesis. Proc. Natl. Acad. Sci. USA, 98: 2515-2520, 2001.
15. Kudo, Y., Kitajima, S., Sato, S., Miyauchi, M., Ogawa, I., and Takata, T. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Cancer Res., 61: 7044-7047, 2001.
16. Chiarle, R., Fan, Y., Piva, R., Boggino, H., Skolnik, J., Novero, D., Palestro, G., De Wolf-Peeters, C., Chilosi, M., Pagano, M., and Inghirami, G. S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase. Am. J. Pathol., 160: 1457-1466, 2002.
17. Masuda, T. A., Inoue, H., Sonoda, H., Mine, S., Yoshikawa, Y., Nakayama, K., Nakayama, K. I., and Mori, M. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis. Cancer Res., 62: 3819-3825, 2002.
18. Wirbelauer, C., Sutterluty, H., Blondel, M., Gstaiger, M., Peter, M., Reymond, F., and Krek, W. The F-box protein Skp2 is a ubiquitylation target of a Cu11-based core ubiquitin ligase complex: evidence for a role of Cu11 in the suppression of Skp2 expression in quiescent fibroblasts. EMBO J., 19: 5362-5375, 2000.
19. Gugneja, S., Virbasius, J. V., and Scarpulla, R. C. Four structurally distinct, non-DNA-binding subunits of human nuclear respiratory factor 2 share a conserved transcriptional activation domain. Mol. Cell. Biol., 15: 102-111, 1995.
20. Watanabe, H., Sawada, J., Yano, K., Yamaguchi, K., Goto, M., and Handa, H. cDNA cloning of transcription factor E4TF1 subunits with Ets and notch motifs. Mol. Cell. Biol., 13: 1385-1391, 1993.
21. Thompson, C. C., Brown, T. A., and McKnight, S. L. Convergence of Ets- and notch-related structural motifs in a heteromeric DNA binding complex. Science (Wash. DC), 253: 762-768, 1991.
22. Rosmarin, A. G., Caprio, D. G., Kirsch, D. G., Handa, H., and Simkevich, C. P. GABP and PU. 1 compete for binding, yet cooperate to increase CD18 (β2 leukocyte integrin) transcription. J. Biol. Chem., 270: 23627-23633, 1995.
23. Hatakeyama, S., Yada, M., Matsumoto, M., Ishida, N., and Nakayama, K. I. U box proteins as a new family of ubiquitin-protein ligases. J. Biol. Chem., 276: 33111-33120, 2001.
24. Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11: 1475-1489, 1983.
25. Sambrook, J., and Russel, D. W. Molecular Cloning: A Laboratory Mannual, 3rd Ed., pp. 17.13-17. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 2001.
26. Shirane, M., and Nakayama, K. I. Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis. Nat. Cell Biol., 5: 28-37, 2003.
27. LaMarco, K., Thompson, C. C., Byers, B. P., Walton, E. M., and McKnight, S. L. Identification of Ets- and notch-related subunits in GA binding protein. Science (Wash. DC), 253: 789-792, 1991.
28. Virbasius, J. V., Virbasius, C. A., and Scarpulla, R. C. Identity of GABP with NRF-2, a multisubunit activator of cytochrome oxidase expression, reveals a cellular role for an ETS domain activator of viral promoters. Genes Dev., 7: 380-392, 1993.
29. Oeda, K., Salinas, J., and Chua, N. H. A tobacco bZip transcription activator (TAF-1) binds to a G-box-like motif conserved in plant genes. EMBO J., 10: 1793-1802, 1991.
30. Tilburn, J., Sarkar, S., Widdick, D. A., Espeso, E. A., Orejas, M., Mungroo, J., Penalva, M. A., and Arst, H. N., Jr. The Aspergillus PacC zinc finger transcription factor mediates regulation of both acid- and alkaline-expressed genes by ambient pH. EMBO J., 14: 779-790, 1995.
31. Wasylyk, B., Hahn, S. L., and Giovane, A. The Ets family of transcription factors. Eur. J. Biochem., 211: 7-18, 1993.
32. Virbasius, J. V., and Scarpulla, R. C. Transcriptional activation through ETS domain binding sites in the cytochrome c oxidase subunit IV gene. Mol. Cell. Biol., 11: 5631-5638, 1991.
33. Rao, V. N., Huebner, K., Isobe, M., ar-Rushdi, A., Croce, C. M., and Reddy, E. S. elk, tissue-specific ets-related genes on chromosomes X and 14 near translocation breakpoints. Science (Wash. DC), 244: 66-70, 1989.
34. Ouyang, L., Jacob, K. K., and Stanley, F. M. GABP mediates insulin-increased prolactin gene transcription. J. Biol. Chem., 271: 10425-10428, 1996.
35. Kamura, T., Handa, H., Hamasaki, N., and Kitajima, S. Characterization of the human thrombopoietin gene promoter. A possible role of an Ets transcription factor, E4TF1/GABP. J. Biol. Chem., 272: 11361-11368, 1997.
36. Sutterluty, H., Chatelain, E., Marti, A., Wirbelauer, C., Senften, M., Muller, U., and Krek, W. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat. Cell Biol., 1: 207-214, 1999.
37. Marti, A., Wirbelauer, C., Scheffner, M., and Krek, W. Interaction between ubiquitin-protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation. Nat. Cell. Biol., 1: 14-19, 1999.
38. Mendez, J., Zou-Yang, X. H., Kim, S. Y., Hidaka, M., Tansey, W. P., and Stillman, B. Human origin recognition complex large subunit is degraded by ubiquitin-mediated proteolysis after initiation of DNA replication. Mol. Cell, 9: 481-491, 2002.
39. Kiernan, R. E., Emiliani, S., Nakayama, K., Castro, A., Labbe, J. C., Lorca, T., Nakayama, K. I., and Benkirane, M. Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasome. Mol. Cell. Biol., 21: 7956-7970, 2001.
40. Charrasse, S., Carena, I., Brondani, V., Klempnauer, K. H., and Ferrari, S. Degradation of B-Myb by ubiquitin-mediated proteolysis: involvement of the Cdc34-SCF(p45Skp2) pathway. Oncogene, 19: 2986-2995, 2000.
41. Tedesco, D., Lukas, J., and Reed, S. I. The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2). Genes Dev., 16: 2946-2957, 2002.
42. Hara, T., Kamura, T., Nakayama, K., Oshikawa, K., Hatakeyama, S., and Nakayama, K. I. Degradation of p27(Kip1) at the G(0)-G(1) transition mediated by a Skp2-independent ubiquitination pathway. J. Biol. Chem., 276: 48937-48943, 2001.
43. Nelsen, C. J., Hansen, L. K., Rickheim, D. G., Chen, C., Stanley, M. W., Krek, W., and Albrecht, J. H. Induction of hepatocyte proliferation and liver hyperplasia by the targeted expression of cyclin E and skp2. Oncogene, 20: 1825-1831, 2001.
44. Flory, E., Hoffmeyer, A., Smola, U., Rapp, U. R., and Bruder, J. T. Raf-1 kinase targets GA-binding protein in transcriptional regulation of the human immunodeficiency virus type 1 promoter. J. Virol., 70: 2260-2268, 1996.
45. Avots, A., Hoffmeyer, A., Flory, E., Cimanis, A., Rapp, U. R., and Serfling, E. GABP factors bind to a distal interleukin 2 (IL-2) enhancer and contribute to c-Raf-mediated increase in IL-2 induction. Mol. Cell. Biol., 17: 4381-4389, 1997.
46. Treisman, R. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol., 8: 205-215, 1996.
47. Hoffmeyer, A., Avots, A., Flory, E., Weber, C. K., Serfling, E., and Rapp, U. R. The GABP-responsive element of the interleukin-2 enhancer is regulated by JNK/SAPK-activating pathways in T lymphocytes. J. Biol. Chem., 273: 10112-10119, 1998.